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Abstract
The goal of our work was to determine which signal sequence helps produce and
secrete the highest amount of the target protein which helps in establishing B. subtilis
bacteria as a vehicle for producing therapeutics. We created fusion constructs consisting
of different signal sequences, the target Hhc protein sequence, the mCherry luorescence
sequence and spectinomycin resistance. The company GenScript was utilized to synthesize
the ten fusion constructs each with a different secretion signal in the plasmid. A
transformation check was performed on B. subtilis to ensure that the fusion construct was
present in the bacterial genome. Liquid cultures of the bacteria were incubated for 18
hours and 42 hours. Lysate samples were obtained and used to run SDS-PAGE analyses
which revealed that there was no signi icant difference between strains that were induced
with IPTG and those that were not. Therefore, we were unable to determine which signal
sequence was optimal to be used when producing therapeutics.
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Introduction and Background
General Bacteria Background
Bacteria are prokaryotes and unicellular. This means that bacteria lack
membrane-bound organelles such as the nucleus, mitochondria, golgi bodies, endoplasmic
reticulum. Without the nucleus, the genetic material is typically stored in an area referred
to as the nucleoid in the cytoplasm. Bacteria contain DNA (Deoxyribonucleic acid) as their
genetic material. This DNA is found in the form of plasmids and in the circular bacterial
chromosomes. Bacteria are generally in three distinct shapes: coccus, spiral, and bacillus.
Coccus shaped means the bacteria is spherical in nature. Multiple coccus bacteria are
referred to as cocci. Cocci can be present as chains of bacteria, as clusters of bacteria, or
simply as pairs (Yang, 2016). Cocci bacteria tend to not have motor parts causing them to
lack motility and be still (Yang, 2016). Spiral bacteria are helical in shape. They are
typically categorized by the number of turns per bacterium and motility (Yang, 2016).
Bacillus shaped means the bacteria are rod-shaped in nature. They can be in pairs forming
diplobacilli, in chains forming streptobacilli, oval-shaped forming coccobacillus, or
arranged like a fence forming palisades (Yang, 2016).
A distinction that can be made within bacteria is regarding their gram status
(Baron, 1996). Gram-positive indicates a thick layer of peptidoglycan, a polymer made up
of N-acetylglucosamines, N-acetylmuramic acids and other short amino acid chains
forming a mesh layer, outside the plasma membrane (Vollmer, 2008). Gram-negative
bacteria have a cell wall that consists of a thin layer of peptidoglycan along with an
additional outer membrane (Baron, 1996). This additional membrane contains
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lipopolysaccharides which consist of Lipid A which is toxic, polysaccharides, and an O
antigen (Sampath, 2018). These lipopolysaccharides provide stability to the membrane
(Sampath, 2018).
Bacterial Secretion Systems
For any bacteria to communicate with the environment, some proteins have to be
transported across the cellular envelope, through two or three layers in gram-positive and
gram-negative organisms respectively. For most bacterial infections to occur, the
pathogens must secrete their proteins across the plasma membrane of the target cells.
Additionally, protein secretion is also important for bacterial growth and development.
The general secretion (Sec) and twin arginine translocation (Tat) are two secretion
systems for proteins that are most commonly used by bacteria (Green, 2016). In fact,
these protein secretion systems are highly conserved for all domains of life (Green, 2016).
In both secretion systems in gram-positive bacteria, they primarily result in proteins being
present outside of the cell (Green, 2016). However in gram-negative bacteria, the proteins
can either be in the periplasmic space or outside of the cell (Green, 2016). While they
share many similarities, they have several fundamental differences in how they achieve
secretion.
The Sec pathway secretes unfolded proteins and is composed of a component that
targets a protein of interest, a motor protein for motility and a channel within the
membrane for transport (Beckwith, 2013). The Sec pathway starts with recognizing the
signal sequence which consists of a positively charged N-terminus, nonpolar core, and a
polar C-terminus (Beckwith, 2013). Generally, proteins that are destined for the outside of
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the cell are identi ied by the SecB protein. SecB binds to the target protein to restrain it
from folding (Tsirigotaki, 2016). Then, the signal sequence is cleaved by a protease
(Tsirigotaki, 2016). The SecA protein functions as an ATPase to supply energy to transport
the target protein across the membrane (Tsirigotaki, 2016). Once on the other side of the
membrane, the protein is allowed to properly fold. In the case of gram-positive bacteria,
the secretion process would end as the protein has successfully made it across the single
membrane. In the case of gram-negative bacteria, the protein needs to utilize either the
Type II or Type V secretion system to move from the periplasmic space to outside the cell
(Green, 2016).
Unlike the Sec pathway, the Tat pathway predominantly secretes folded proteins
(Berks, 2015). This is a fundamental difference because some post-translational
modi ications and certain environmental conditions are essential for the folding process
and cannot be found outside of the cytoplasm (Lee, 2006). Therefore, these protein
products must be fully folded before they can be allowed to be transported outside the
cell (Berks, 2015). Similar to the Sec pathway, the Tat pathway requires a N-terminal Tat
signal sequence to begin the secretion process. The signal sequence consists of a Serine,
Arginine and Arginine on the N-terminus of the protein (Lee, 2006). Once it is recognized,
the TatB and TatC bind to this signal sequence, TatA is then mobilized (Lee, 2006). This
trimeric complex results in the formation of a channel that spans the membrane and is
used for the secretion of the target protein (Berks, 2015). Similar to the Sec pathway, in
gram-positive bacteria, the protein is secreted to the extracellular environment but in
gram-negative bacteria, the Type II system is recruited for extracellular secretion.
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Although not as commonly used in bacterial species, the Type VII secretion system
is versatile. In gram-positive bacteria where a mycomembrane is present, the Type VII
secretion system is used although the system can be functional in other bacterial species
as well, such as B. subtilis (Unnikrishnan, 2017). Chaperone proteins recognize the
C-terminal signal sequence and direct the protein towards the secretion apparatus (Ates,
2016). The T7SS apparatus is utilized and it consists of the proteins EccB, EccC, EccD, EccE,
and MycP (Ates, 2016). The tetrameric Ecc proteins generate a channel for the transport
of the protein of interest across the membrane (Ates, 2016). Another protein that is
involved in the Type VII secretion system but is not well understood is the MycP protein
(Ates, 2016). It is believed to be a key regulator for secretion but further conclusive
research is required (Green, 2016).
Bacterial Usage for Therapeutics
Bacteria are commonly used for the production of therapeutics because they are
cost-effective to maintain, grow rapidly, their genomes are well understood, can easily be
genetically engineered, and can be easily scaled up as bioreactors to produce the protein
product in large quantities (Jozala, 2016). Additionally, bacteria can be stored at -80 °C for
long periods of time making them conducive for effective storage of genes (Jozala, 2016).
Currently, the spectrum of the protein-based therapeutics is being expanded to
post-translationally modi ied proteins with the system developed in Escherichia coli, a
rod-shaped bacterium. Nevertheless, E. coli is a gram-negative bacterium which indicates
that it has two membranes that are hard for proteins to travel through (Baron, 1996).
Therefore, the majority of biomaterials are produced in E. coli cells intracellularly and are
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puri ied from the lysed cells. This adds an additional layer of complexity and danger of
residual lipopolysaccharides, normally present outside the cell membrane, being present
in the obtained preparations. These are highly toxic even when present in low
concentrations.
The production and secretion of the desired protein into the extracellular
environment is bene icial as it is simpler than purifying from lysed cells and risking
lipopolysaccharide presence as would be expected when using gram negative bacteria like
E. coli. To alleviate these issues and to take advantage of the cutting edge
post-translationally modi ied protein-based material, Bacillus subtilis is being used. It is a
gram-positive bacterium, an industrially-used microorganism without a double membrane,
often used for protein product secretion (Nijland, 2008). B. subtilis is highly relevant for
industrial preparation of proteins, primarily enzymes. They are preferred due to their
cost-effectiveness for culture preparation (Nijland, 2008). Additionally, this organism is
generally recognized as safe (GRAS status) for usage in many laboratory settings (Nijland,
2008).
Fusion Constructs and Components
The constructs consist of a signal sequence, Hedgehog (Hhc) protein sequence,
mCherry sequence, and spectinomycin resistance sequence were created. A simple
representation of the fusion construct is visualized below in Figure 1. The goal of this
project is to determine which of the ten different fusion constructs each with their
corresponding signal sequences both produces and secretes the highest amount of the
target protein, HHc, in B. subtilis bacteria.
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Figure 1: A simple, schematic representation of the fusion constructs.
The process of production and secretion of proteins starts with the transcription of
the target gene using an effective promoter and translation of the gene to the
corresponding protein via ef icient ribosome binding sites (Nijland, 2008). Then, the signal
sequence found in the fusion construct on the target protein aids in recognition and
translocation across the plasma membrane using the appropriate secretion pathway like
sec, tat, or type 7 (Nijland, 2008). This sequence is speci ic to the secretion system used
(Martoglio, 1998). When the fusions are created, the signal sequence is attached to the
N-terminus of the target protein, in this case Hhc (Freudl, 2018). Additionally, the signal
sequences affect the stability of the protein and its rate of folding (Freudl, 2018). Once the
protein successfully translocates, the signal sequence is cleaved and chaperone proteins
assist in the proper folding of the target polypeptide, if required such as in the general
secretion system which transports unfolded proteins (Burdette, 2018). In the case of
misfolding, proteases located on the cell wall degrade the misfolded protein (Burdette,
2018). Otherwise, the target protein is then secreted.
The hedgehog protein plays a signi icant role in signalling for animal development
and is part of a crucial signal transduction pathway (Farzan, 2008). As such, it is often
investigated as part of novel stem cells and anti-cancer therapies (Farzan, 2008). It was
originally discovered in the fruity ly family, Drosophila, where it played a role in
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pigmentation patterning but has been identi ied in most animal genomes (Burglin, 2008).
It is able to post-translationally modify itself by using the protease within the sequence to
autocatalytically cleave itself (Burglin, 2008). HhC is also able to add cholesterol
molecules to create novel therapeutics (Burglin, 2008). Therefore, this protein is targeted
to be produced and exported from B. subtilis bacteria.
mCherry is a protein that is frequently utilized in biological applications for
luorescent tagging (Zyl, 2015). This is a variant of the red luorescent protein DsRed
which was isolated from Discosoma sea anemones (Day, 2009). mCherry absorbs light at
587 nm and emits at 610 nm, producing red luorescence (Day, 2009). mCherry has been
used in many studies with B. subtilis where it was proven that even at high levels of
mCherry expression, there was no negative effect to the cell (Zyl, 2015). This is imperative
as luorescent markers must not interfere with normal cellular functions. mCherry gene is
generally added to the plasmid along with a target gene’s ORF to be integrated into the
host organism’s genome and checked whether the gene of interest, fused with the
mCherry, is expressed. In this case, red luorescence would indicate expression of the
target gene.
General Bacterial Transformation
Transformation and integration are key methods through which plasmids can be
provided to bacterial species (Johnston, 2014). Speci ically designed plasmid constructs
are created to be transformed and maintained inside bacterial cells, such as E. coli. In
some cases, integration into the bacterial genome is possible, for example in the case of
the marker replacement strategy in B. subtilis. E. coli are allowed to take up the plasmid
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through two common laboratory methods. The irst is through a heat-shock
transformation (Rahimzadeh, 2016). The cells are incubated with CaCl2 to increase the
permeability of the cell membrane (Rahimzadeh, 2016). Then the cells are incubated in
ice, heated and incubated in ice, allowing plasmid uptake to occur (Rahimzadeh, 2016).
The second most common method for bacterial transformation is electroporation (Chassy,
1988). The cells are subject to brief exposure to high-voltage electricity to form temporary
pores within the membrane, allowing for plasmid uptake (Chassy, 1988). After either
method, bacteria that have internalized the plasmid can be selected for by growing them
on a medium with the antibiotic. Only, those that did take up the plasmid would survive as
they contain the resistance gene for the antibiotic.
General Bacterial Transcription
After bacterial transformation, transcription of the gene of interest can be induced
in many ways. One method is through the induction mechanism of the lac operon which
consists of a promoter, an operator (lacO sites), and structural genes (Donovan, 1996).
Normally, the regulator gene that is upstream produces a repressor protein that binds to
the operator preventing RNA polymerase from binding and transcription to occur
(Donovan, 1996). With the use of an inducer such as lactose or in this case Isopropyl βd-1-thiogalactopyranoside (IPTG), the inducer will bind to the repressor, inactivating the
repressor protein and preventing it from binding to the operator (Lewis, 2005). Thus,
transcription occurs. In this manner, the lac operon is always off and the genes present in
the lac operon have low levels of transcription unless in the presence of an inducer.
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Figure 2: Control of a promoter with lacO operator sites for inducible expression of a
protein.
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Materials and Methods
Fusion constructs consisting of a signal sequence, Hhc protein sequence, mCherry
sequence, and spectinomycin resistance sequence were created using the online-based
bioinformatics software package Benchling (https://www.benchling.com). Ten fusion
constructs were synthesized by the company Genscript using the corresponding signal
sequences found below in Table 1, with each plasmid containing a different secretion
signal. In the Sysoeva lab, these plasmids were transformed into B. subtilis carrying
kanamycin resistance. The original kanamycin resistance gene already present in the
bacteria was then replaced with spectinomycin resistance from the construct.
Table 1: Signal sequences used for fusions
Strain # Tag

Secretion
Pathway

Nucleotide sequence 5’-3’

Molecular
Weight (kDa)

SL 33

Epr

sec
(N-terminus)

AAAAACATGTCTTGCAAACTTGTTGTTTCTGTTA
CACTTTTCTTCTCTTTCCTTACAATCGGCCCTCTT
GCTCATGCTGCGAGTGCTGCG

56.397

SL 34

TasA

sec
(N-terminus)

GGTATGAAAAAGAAATTGAGTTTAGGAGTTGCTT
CTGCAGCACTAGGATTAGCTTTAGTTGGAGGAGG
AACATGGGCAGCATTTGCGAGTGCTGCG

56.248

SL 35

TasA
full

sec
(N-terminus)

GGTATGAAAAAGAAATTGAGTTTAGGAGTTGCTT 81.446
CTGCAGCACTAGGATTAGCTTTAGTTGGAGGAGG
AACATGGGCAGCATTTAACGACATTAAATCAAAG
GATGCTACTTTTGCATCAGGTACGCTTGATTTATC
TGCTAAAGAGAATTCAGCGAGTGTGAACTTATCA
AATCTAAAGCCGGGAGATAAGTTGACAAAGGATT
TCCAATTTGAAAATAACGGATCACTTGCGATCAAA
GAAGTTCTAATGGCGCTTAATTATGGAGATTTTAA
AGCAAACGGCGGCAGCAATACATCTCCAGAAGAT
TTCCTCAGCCAGTTTGAAGTGACATTGTTGACAGT
TGGAAAAGAGGGCGGCAATGGCTACCCGAAAAAC
ATTATTTTAGATGATGCGAACCTTAAAGACTTGTA
TTTGATGTCTGCTAAAAATGATGCAGCGGCTGCTG
AAAAAATCAAAAAACAAATTGACCCTAAATTCTT
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AAATGCAAGCGGTAAAGTCAATGTAGCAACAATT
GATGGTAAAACCGCTCCTGAATATGATGGTGTTCC
AAAAACACCAACTGACTTCGATCAGGTTCAAATG
GAAATCCAATTCAAGGATGATAAAACAAAAGATG
AAAAAGGGCTTATGGTTCAAAATAAATATCAAGG
CAACTCCATTAAGCTTCAATTCTCATTCGAAGCTA
CACAGTGGAACGGCTTGACAATCAAAAAGGACCA
TACTGATAAAGATGGTTACGTGAAAGAAAATGAA
AAAGCGCATAGCGAGGATAAAAATGCG
SL 36

YjfA

sec
(N-terminus)

AAACGTCTTTTCATGAAAGCTTCTCTTGTTCTTTT 56.482
CGCTGTTGTTTTCGTTTTCGCTGTTAAAGGCGCTC
CTGCTAAAGCTGCGAGTGCTGCG

SL 37

YukE

t7
(N-terminus)

GCAGGATTAATTCGTGTCACACCCGAAGAGCTAAG 64.435
AGCGATGGCGAAGCAATACGGCGTTGAAAGCCAA
GAAGTATTAAATCAGGTTGATCGTTTAAACCGAAT
GATCTCTGATTTGAAAAGCATGTGGGAAGGTGCT
TCAAGCGAAGCGTTCGCAGATCAATACGAGCAGCT
CAAACCTTCATTTATCAAAATGTCAGATTTGCTTC
AAGATGTGAATCAGCAGCTTGATCAAACAGCAAA
TACACTTGAGTCTACTGACCAAGACATCGCAAATC
AAATCCGCGGAGCGAGTGCTGCG

SL 38

YwbN

tat
(N-terminus)

AGCGATGAACAGAAAAAGCCAGAACAAATTCACA
GACGGGACATTTTAAAATGGGGAGCGATGGCGGG
GGCAGCCGTTGCGATCGGTGCCAGCGGTCTCGGCG
GTCTCGCTCCGCTTGTTGCGAGTGCTGCG

SL 39

PhoD

tat
(N-terminus)

GCATACGACAGTCGTTTTGATGAATGGGTACAGAA 58.851
ACTGAAAGAGGAAAGCTTTCAAAACAATACGTTT
GACCGCCGCAAATTTATTCAAGGAGCGGGGAAGA
TTGCAGGACTTTCTCTTGGATTAACGATTGCCCAG
GCGAGTGCTGCG

SL 40

TorA

tat
(N-terminus)

AACAATAACGATCTCTTTCAGGCATCACGTCGGCG
TTTTCTGGCACAACTCGGCGGCTTAACCGTCGCCG
GGATGCTGGGGCCGTCATTGTTAACGCCGCGACGT
GCGACTGCGGCGAGTGCTGCG

SL 41

AmyE

sec
(N-terminus)

TTTGCAAAACGATTCAAAACCTCTTTACTGCCGTT 56.733
ATTCGCTGGATTTTTATTGCTGTTTCATTTGGTTC
TGGCAGGACCGGCGGCTGCGAGTGCTGCG

SL 42

YncM

sec
(N-terminus)

GCTAAACCTCTTTCTAAAGGCGGCATCCTTGTTAA 57.432
AAAAGTTCTTATCGCTGGCGCTGTTGGCACAGCTG
TTCTTTTCGGCACACTTTCTTCTGGCATCCCTGGC
CTTCCTGCTGCTGATGCTGCGAGTGCTGCG

57.686

57.658
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To ensure integration has occurred properly, an antibiotic resistance check was
performed. First, agar was made by mixing 25 g of Difco Lysogeny broth (LB) and 15 g of
Agar in 1 L of dH2O. A stirrer was placed in the 1 L lask so a homogenous mixture could
be obtained. The mixture was then autoclaved using Round 3 for 45 mins before it was left
to cool. At this point, antibiotics were added to the mixture, if necessary. Next, plates were
obtained, separated into manageable stacks, and poured starting from the bottom plate of
the stack. During this process, a Bunsen burner was used to sterilize lab materials and the
mouth of the lask was lamed in between pouring. The stacks of plates were then marked
as per antibiotics or lack thereof on the plates for identi ication. Using the procedure
above, plain LB, LB+Spectinomycin, and LB+Kanamycin plates were poured. To perform
the transformation check, strains SL 12 and 17 whose resistances are known were
streaked (Refer to the streaking procedure below) on LB plates. Strains SL 33-37 were
streaked on LB plates from freezer stock. After making sure the strains have been revived,
strains SL 33-37 were then streaked on both spectinomycin and kanamycin plates.
The streaking procedure is as follows. First, all lab materials and the work area
were sterilized. The plate we are streaking onto was placed facing up and the plate we are
streaking from was placed facing down. A single colony was selected, swiped onto the new
plate, and dragged down a little bit using a toothpick. Then, a new toothpick was used to
drag the earlier markings and make more swipes making sure that they do not touch the
prior markings. This was repeated one or two additional times, depending on space, to
allow for single colonies to show up.
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To test for expression of the protein, liquid cultures were made from the colonies
after streaking. First, 4 mL of LB stock was added to a culture tube along with 4 μL of
IPTG, an inducer that triggers transcription. A colony from the SL 33 strain plate was
scooped using a toothpick, and washed with the LB stock and inducer solution. This was
repeated for the remaining strains SL 34-37. Then, the procedure was repeated without
the addition of IPTG for all strains SL 33-37, creating ive culture tubes with the inducer
(+) and ive culture tubes without the inducer (-). These ten culture tubes were incubated
at 37 °C with aeration at 200 rpm (18 hours during the irst iteration and 42 hours during
the second iteration).
After incubation, lysate samples were created for strains SL 33-37 by preparing
the following four solutions.
-

Lysis buffer: 20 mM Tris 7.5, 10 mM EDTA, 1mg/mL lysozyme, 1 mM PMSF

-

1x Tris Glycine Buffer 9:1 ratio: 100 mL of 10x Tris, 900 mL of ddH2O

-

2x Sample Buffer: 4% SDS 20 mL 10% SDS, 250 mM Tris 6.8 12.5 mL 1M Tris 6.8,
20% glycerol 10 mL 100% , 10 mM EDTA 1 mL 0.5M EDTA, BPB (Bromophenol
blue) 200 μl 1% stock, H2O 1.3 mL

-

Lysozyme (10 mg/mL): Solid lysozyme at a concentration of 10 mg/mL was
dissolved in 10 mM Tris-Cl (pH 8.0) immediately before use.

A 1.5 mL sample from each of the ten culture tubes was obtained and transferred to a
small centrifuge tube. These ten sample centrifuge tubes were centrifuged at 14000 rpm
in Eppendorf 5430R centrifuge for 2 minutes at room temperature. The supernatants
were discarded and the pellets were left in the centrifuge tube. 50 μL of lysis buffer was
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added to each centrifuge tube and the pellets were resuspended by vortexing. The
centrifuge tubes were then incubated at 37 °C for 10 minutes and vortexed for a minute
with a minimal amount of small glass beads. Next, a solution of 900 μL of 2X sample
buffer, 100 μL of BME, and 50 μL Bromophenol blue was prepared and 50 μL of this
solution was added to each centrifuge tube. The centrifuge tubes were again vortexed for
a minute and a hole was made in the lid. Then, the centrifuge tubes were heated for ive
minutes at 80-95 °C in the tube heater.
10% SDS PAGE gels of 1 mm were prepared by irst rinsing the glass plates and
short plates using dH2O and then with ethanol. Next, the gel cassette was set up and the
running gel solution was made by mixing 5.3 mL of dH2O, 3.8 mL of 40% acrylamide
(29:1), 5.6 mL of 1M Tris pH 8.9, 150 µL of 10% SDS, 100 µL of 10% Ammonium
persulfate (APS), and 15 µL of tetramethylethylenediamine (TEMED). APS and TEMED
were added last to initiate and catalyze polyacrylamide gel polymerization. The running gel
solution was then poured into the gap between the plates leaving about 3 cm from the top
of the short plate for the stacking gel. Ethanol was added to cover up the top of the gel
while it polymerized for about two hours. The ethanol was removed and dH2O was used to
rinse the top of the gel. The stacking gel solution was then prepared by mixing 3.9 mL of
dH2O, 0.38 mL of 40% acrylamide (29:1), 0.63 mL of 1M Tris pH 6.8, 50 µL of 10% SDS, 35
µL of 10% APS, and 5 µL of TEMED. The stacking gel solution was poured on top of the
running gel till the top of the short plate. The comb was inserted and the gel was allowed
to polymerize for two hours. When polymerization inished, the comb was removed
before the gel “sandwich” was removed from the cassette setup. The glass plate and short
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plate were wrapped together in a paper towel soaked in dH2O, used or stored in the fridge
until use.
To load the samples into the gel, the plastic SDS holder, SDS materials, and gel
from the fridge were obtained. The gel was placed in the running cassette with the short
plate facing inside. Then, the iller cassette was placed on the other side. The middle
portion of the SDS holder was completely illed with 1x Tris Glycine buffer. The outer
portion was illed halfway with 1x Tris Glycine buffer. 4 μL of protein ladder was loaded in
the irst well. Then, 4 μL of the heated lysate samples of strains SL 33-37 were loaded in
the following wells alternating uninduced (-) and induced (+) samples. The lid of the SDS
holder was secured and the current was turned on to 80 V. After 20 minutes, the voltage
was increased to100 V. After another 20 minutes, the voltage was increased to 120 V. The
current was turned off after the smallest marker from the protein ladder sample had
reached the bottom.
To stain and destain the gel using the Coomassie stain, the gel was removed from
the apparatus. A scraper was used to cut off the stacking gel area and obtain a lat
rectangular piece of gel with the banding. The gel was then placed in a microwavable
container and the coomassie stain solution was used to submerge the gel. This was left to
sit for 10-15 minutes. The gel was destained by removing the stain solution from the
microwavable container. dH2O was added to the container and microwaved for 30
seconds. This process was repeated 5-6 times to aid in the destaining process and
increase the visibility of the banding. The inished gel is then submerged in enough dH2O
and stored at room temperature in the container.
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Results and Discussion

Figure 3: Test strains on LB plates
To con irm that the plasmids encoding fusion proteins were successfully integrated
into B. subtilis chromosome, we proceeded with the transformation check. As seen in
Figure 3, all of the test strains (SL33-SL37) were streaked on LB plates from the freezer
stocks. The growth indicates that the strains have been successfully revived. Next, after the
test strains have been revived, we wanted to ensure that the plates had their respective
antibiotics, and were functioning as expected. To do so, the control strains SL 12 and 17
were utilized. Strain SL 12 is known to be kanamycin resistant while strain SL 17 is known
to be spectinomycin resistant. Therefore, SL 12 was streaked on a LB + kanamycin plate
and SL 17 was streaked on a LB + spectinomycin plate. As can be seen in Figure 4, control
strain SL12 grew on the kanamycin plate and control strain SL17 grew on the
spectinomycin plate. This indicates that these plates work as expected.
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Figure 4: Control strains on their respective antibiotic resistant plates
After the test strains were revived and the functionality of the plates has been
checked, we proceeded to check the antibiotic resistances of the test strains using the
tested plates. The test strains did not have spectinomycin resistance originally but should
have gained spectinomycin resistance through transformation and integration. Therefore,
if transformation was successful, the bacteria should grow on LB+spectinomycin plates. As
observed in Figure 5, the bacteria performed as expected indicating that transformation
was successful. The test strains originally had kanamycin resistance but should have lost
this resistance after the transformation and integration of the fusion construct. This is
because the insertion of the fusion construct effectively knocks out the original kanamycin
resistance. Therefore, if this process was successful, the bacteria should not grow on LB +
kanamycin plates. As observed in Figure 6, no growth was observed so the bacteria
performed as expected indicating that transformation was successful. Based on all of
these observations, we concluded that the marker replacement has occurred.
No pink or red colonies were present in Figure 5 which was expected since the
IPTG inducer was not added to the plates and the promoter is switched off by default.
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Since the integration check using plates does not give us enough information about the
production of the target protein, an expression check was performed.

Figure 5: Test strains on LB +
spectinomycin plates

Figure 6: Test strains on LB +
kanamycin plates

After the transformation check has occurred, we proceeded to perform an
expression check to observe the level of protein expression in the test strains SL 33-37 by
running a SDS-PAGE analysis. Coomassie staining was then used for the resulting gel to
see the presence of proteins. This helped in checking if the gene of interest was expressed.
Hhc, our target protein, has a molecular weight of 25.84 kD. However, the different fusions
have different molecular weights as seen in Table 1. Regardless of which fusion was used,
we expect to see a larger or brighter band on the gel in the strains induced with IPTG (+)
compared to the uninduced (-) strains. The irst iteration gel was run using liquid cultures
that were incubated for 18 hours after induction by IPTG. The protein is expected to be
seen about one-thirds of the way down the gel to analyze if the target protein has been
produced but not ef iciently secreted. However, as can be seen in Figure 7 below, no
difference in banding is visible between each uninduced (-) and induced (+) strain near
the 25 kD marker. Additionally, a general analysis of the gel was done and two
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observations were made. The leftmost star on Figure 7 is to bring attention to the banding
of 34- and 34+ in that area where the uninduced strain seems to have a brighter band,
indicating more protein. This is different from the rest of the strains where the uninduced
strain’s banding is lighter in that area. The rightmost star on Figure 7 is to show that strain
35, both induced and uninduced, has a band in that area that other strains do not have.
Other than these two observations, there is not a noticeable difference between the
banding patterns of the induced and uninduced strains. Hence, the experiment was
repeated with a 42 hour incubation period for the liquid cultures. It was expected that
allocating more time for incubation would allow more time for the target protein to be
produced.

Figure 7: Gel 1 with 18 hour incubation period
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Figure 8: Gel 2 with 42 hour incubation period
Even in the second iteration of the experiment a difference was not seen in protein
production with or without induction. This may be because the protein is not being
produced at all, or not enough of it is being produced to be seen on the gel. Another
circumstance would be that the target protein is being produced and secreted so
ef iciently that no Hhc protein can be detected in the intracellular samples. Based on the
results from both of the iterations, we are unable to detect expression of our fusion
constructs in B. subtilis to determine which signal sequence resulted in the greatest
production and secretion of the Hhc protein.
In the future, a more accurate transformation check should be performed by using
PCR and sequencing the DNA to ensure the fusion construct, with the target gene, the
signal sequence, spectinomycin resistance, and mCherry sequence, are actually present in
the chromosomal DNA of the B. subtilis bacteria indicating successful integration.

24

Additionally, since the goal is to not just produce the HhC fusion proteins in the cell cytosol
but to secrete them to the extracellular environment, it would be bene icial if the secretion
check was performed using spent media. The spent media, with the overall dilution of
proteins, must be concentrated by ultra iltration or utilization of a vacuum to evaporate
the excess water.
The western blot technique can also be performed on both the cell lysates and the
spent media as this technique enables more sensitive and speci ic protein detection due to
speci ic binding through antibodies, in contrast to non-speci ic Coomassie staining.
Additionally, staining using an immunoassay will mark the presence of the protein of
interest even if there is a low level of production that the Coomassie staining did not label.
As the designed constructs contain a His-tag on their C-terminus, Nickel-af inity
puri ication can also be done to obtain the proteins on the nickel resin allowing for the
separation and concentration of the protein of interest.
The results of these additional experiments will help determine which fusion
results in the highest production and which signal sequence allows for ef icient secretion
of the produced fusion out of the cells. This ultimately will bring us closer to establishing
B. subtilis bacteria as a vehicle capable of production and secretion of novel
post-translationally modi ied protein therapeutics.
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